Research study Program year 2024 Source: CMS Open Payments

Phase II Antifgfr 1 in Nash

Research payments

$6,491,647

715 payments

Through program year 2024, $6,491,647 in research payments was reported against Phase II Antifgfr 1 in Nash, across 715 payments, paid by Genentech, Inc..

Paid by
Genentech, Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

6 rows
Year Kind Amount Payments
2024 Research $217,881 11
2023 Research $939,706 95
2022 Research $2,254,657 214
2021 Research $2,312,524 249
2020 Research $765,195 144
2019 Research $1,684 2

Breakdown

Who paid Research payments · program years 2019–2024
  1. Genentech, Inc. $6,491,647 715 payments
Who received the money Research payments · program years 2019–2024
  1. Pinnacle Clinical Research Pllc Organisation paid for research $1,049,352 82 payments
  2. Fresno Clinical Research Center Organisation paid for research $495,878 9 payments
  3. National Research Institute Organisation paid for research $456,127 31 payments
  4. Excel Medical Clinical Trials LLC Organisation paid for research $428,781 28 payments
  5. The Institute For Liver Health Organisation paid for research $419,693 62 payments
  6. Andrew J Lewin Medical Corp National Research Institute Organisation paid for research $245,350 32 payments
  7. Clinical Trials Of Texas INC Organisation paid for research $235,314 39 payments
  8. Kansas City Research Institute LLC Organisation paid for research $233,549 10 payments
  9. Texas Digestive Disease Consultants Pllc Organisation paid for research $227,600 39 payments
  10. Conquest Clinical Research LLC Organisation paid for research $198,786 34 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record